160 related articles for article (PubMed ID: 18375525)
1. Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine.
Jaeger G; Bauer F; Brezinschek R; Beham-Schmid C; Mannhalter C; Neumeister P
Ann Oncol; 2008 May; 19(5):1025-6. PubMed ID: 18375525
[No Abstract] [Full Text] [Related]
2. Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome).
Motta G; Vianello F; Menin C; De Nicolo A; Agata S; Altavilla G; Pietrogrande F; Girolami A
Am J Hematol; 2002 Apr; 69(4):272-6. PubMed ID: 11921021
[TBL] [Abstract][Full Text] [Related]
3. Rare variety of T-cell lymphoma.
Pednekar S; Morge V; Rawal S; Korivi D; Ramteke V; Naik K
J Assoc Physicians India; 2011 Oct; 59():667-8. PubMed ID: 22479752
[TBL] [Abstract][Full Text] [Related]
4. Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
Tey SK; Marlton PV; Hawley CM; Norris D; Gill DS
Am J Hematol; 2008 Apr; 83(4):330-3. PubMed ID: 17876769
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in gammadelta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders.
Salhany KE; Feldman M; Peritt D; Nowell PC
Blood; 1997 May; 89(9):3490-1. PubMed ID: 9129060
[No Abstract] [Full Text] [Related]
6. Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma.
Arcaini L; Orlandi E; Scotti M; Brusamolino E; Passamonti F; Burcheri S; Colombo N; Vanelli L; Sbalzarini G; Lazzarino M
Clin Lymphoma; 2004 Mar; 4(4):250-2. PubMed ID: 15072617
[TBL] [Abstract][Full Text] [Related]
7. [A case of effective use of alemtuzumab in a male patient with T-cell lymphoma].
Sokolov AH; Parovichnikova EN; Isaev VG; Ustinova EN; Shavlokhov VS; Atopkov VA; Model SV; Tsyba NN; Kaplanskaia IB; Kliasova GA; Aleksanian MZh; Vishnevskaia ES; Togonidze DK; Mirzoian EE; Savchenko VG
Ter Arkh; 2004; 76(12):73-5. PubMed ID: 15724932
[No Abstract] [Full Text] [Related]
8. Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma.
Suarez F; Wlodarska I; Rigal-Huguet F; Mempel M; Martin-Garcia N; Farcet JP; Delsol G; Gaulard P
Am J Surg Pathol; 2000 Jul; 24(7):1027-32. PubMed ID: 10895827
[TBL] [Abstract][Full Text] [Related]
9. [Primary hepatic lymphoma - favorable outcome with chemotherapy plus rituximab].
Serrano-Navarro I; Rodríguez-López JF; Navas-Espejo R; Pérez-Jacoiste MA; Martínez-González MA; Grande C; Prieto S
Rev Esp Enferm Dig; 2008 Nov; 100(11):724-8. PubMed ID: 19159179
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas.
Weidmann E; Hess G; Chow KU; Krause SW; Subklewe M; Kruse J; Weisel KC; Soekler M; Kim SZ; Napieralski S; Rech J; Dreyling M; Jäger E; Mitrou PS
Leuk Lymphoma; 2010 Mar; 51(3):447-55. PubMed ID: 20141439
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature.
Domm JA; Thompson M; Kuttesch JF; Acra S; Frangoul H
J Pediatr Hematol Oncol; 2005 Nov; 27(11):607-10. PubMed ID: 16282893
[TBL] [Abstract][Full Text] [Related]
12. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
Win N; Tiwari D; Keevil VL; Needs M; Lakhani A
Hematology; 2007 Apr; 12(2):159-62. PubMed ID: 17454198
[TBL] [Abstract][Full Text] [Related]
13. 2'-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma.
Grigg AP
Leuk Lymphoma; 2001 Aug; 42(4):797-9. PubMed ID: 11697510
[TBL] [Abstract][Full Text] [Related]
14. An update on the role of high-dose therapy with autologous or allogeneic stem cell transplantation in mantle cell lymphoma.
Jacobsen E; Freedman A
Curr Opin Oncol; 2004 Mar; 16(2):106-13. PubMed ID: 15075900
[TBL] [Abstract][Full Text] [Related]
15. Pralatrexate-based therapy induced response in an adolescent with refractory hepatosplenic T-cell lymphoma.
Dhir A; Hill B; Waite ES; Cairo MS; Xavier AC
Pediatr Blood Cancer; 2020 Nov; 67(11):e28460. PubMed ID: 32860655
[No Abstract] [Full Text] [Related]
16. A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL).
Nabhan C; Patton D; Gordon LI; Riley MB; Kuzel T; Tallman MS; Rosen ST
Leuk Lymphoma; 2004 Nov; 45(11):2269-73. PubMed ID: 15512816
[TBL] [Abstract][Full Text] [Related]
17. A rare cause of Fever, hepatosplenomegaly, and thrombocytopenia: hepatosplenic gamma/delta T-cell lymphoma.
Albayrak M; Balcik OS; Alan S; Dıncer SL; Yüksel MK; Albayrak A
Pathol Oncol Res; 2011 Jun; 17(2):421-3. PubMed ID: 21197592
[No Abstract] [Full Text] [Related]
18. Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies.
Faderl S; Thomas DA; O'Brien S; Garcia-Manero G; Kantarjian HM; Giles FJ; Koller C; Ferrajoli A; Verstovsek S; Pro B; Andreeff M; Beran M; Cortes J; Wierda W; Tran N; Keating MJ
Blood; 2003 May; 101(9):3413-5. PubMed ID: 12522009
[TBL] [Abstract][Full Text] [Related]
19. Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine.
Navarro JT; Ribera JM; Mate JL; Granada I; Juncà J; Batlle M; Millá F; Feliu E
Leuk Lymphoma; 2003 Mar; 44(3):531-3. PubMed ID: 12688327
[TBL] [Abstract][Full Text] [Related]
20. Primary diffuse large B-cell lymphoma of the testis relapsing in the right atrium.
Yamamoto E; Tomita N; Ishigatsubo Y
Br J Haematol; 2015 Feb; 168(4):469. PubMed ID: 25403768
[No Abstract] [Full Text] [Related]
[Next] [New Search]